0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Repeat stereotactic body radiotherapy for oligometastatic disease.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Patients with oligometastatic disease (OMD) treated with metastasis-directed definitive local therapy such as stereotactic body radiotherapy (SBRT) are at risk of developing new metastases. Here, we compare characteristics and outcomes of patients treated with a single course and repeat SBRT.

          Related collections

          Author and article information

          Journal
          Radiother Oncol
          Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
          Elsevier BV
          1879-0887
          0167-8140
          Jul 2023
          : 184
          Affiliations
          [1 ] Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Rämistrasse 100, 8091 Zurich, Switzerland; Center for Proton Therapy, Paul Scherrer Institute, Forschungsstrasse 111, 5232 Villigen, Switzerland.
          [2 ] Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Rämistrasse 100, 8091 Zurich, Switzerland.
          [3 ] Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Rämistrasse 100, 8091 Zurich, Switzerland. Electronic address: nicolaus.andratschke@usz.ch.
          Article
          S0167-8140(23)00209-8
          10.1016/j.radonc.2023.109671
          37059336
          a788da81-ee48-4896-b458-815f640f5220
          History

          Repeat stereotactic body radiotherapy,Metastasis-directed therapy,Oligometastatic disease

          Comments

          Comment on this article